Polaris Capital

Bando Chemical to Bolster Medical Device Business With Acquisition of Aimedic MMT

Bando Chemical Industries Ltd. (TYO:5195) announced on April 5 that it signed a share purchase agreement to acquire all shares of Aimedic MMT Co. Ltd., a manufacturer, seller and provider of after-sale services for orthopedic medical devices. Acquired from a fund managed by the Polaris Capital Group Co. Ltd. for around 10.55 billion yen ($94.23 million), Aimedic MMT will become...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
Continue Reading